IFP Advisors
AKTS icon

IFP Advisors’s Aktis Oncology AKTS Stock Holding History

IFP Advisors’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.97K Hold
101
– – ﹤0.01% 4231
2026
Q2 		$3.26K Buy
+101
New +$2.07K ﹤0.01% 4017

Other funds holding AKTS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Mirador Capital Partners
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
NLB Skladi upravljanje premozenja
NLB Skladi upravljanje premozenja Ljubljana $2.71B AUM 53.8% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

IFP Advisors's AKTS Position: Q3 2026 in Review

IFP Advisors held its Aktis Oncology (AKTS) position steady in Q3 2026 at 101 shares worth $1.97K. The position accounts for ﹤0.01% of the portfolio, ranked #4231.

IFP Advisors first reported a position in AKTS in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.26K in Q2 2026. 39 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

  • IFP Advisors held 101 shares of Aktis Oncology worth $1.97K as of Q3 2026.
  • IFP Advisors left its Aktis Oncology share count unchanged in Q3 2026.
  • Aktis Oncology made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4231 holding.
  • IFP Advisors first reported a position in Aktis Oncology in Q2 2026 and has held it in 2 quarters since.
  • IFP Advisors's Aktis Oncology position peaked at $3.26K in Q2 2026.
  • 39 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.